Cancers are characterized by a high metabolic heterogeneity allowing cancer cells to survive and proliferate under microenvironment- and therapy-induced stress conditions. Recent technical developments have revealed the spatially- and temporally-resolved complexity of the metabolic networks within tumors and its role in tumor initiation and progression. The 11th ISCaM meeting, in Brussels (Belgium), will gather renowned experts in the cancer metabolism field to discuss the most recent knowledge related to metabolic alterations in cancer, and how this can be translated to the clinics to treat cancer patients.
Topics: Immunometabolism, Lipid metabolism and ferroptosis, Metabolism and therapy resistance, Tumor microenvironment and disease progression, Epigenetics, circadian clock and cancer metabolism, Tumor acidosis and imaging